Lars Bullinger

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia

Intensive Care Unit

Peritoneal Dialysis

Top Venues

Case reports in hematology

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Livius Penter, Nicoletta Cieri, Katie Maurer, Marwan Kwok, Haoxiang Lyu, Wesley S Lu, Giacomo Oliveira, Satyen H Gohil, Ignaty Leshchiner, Caleb A Lareau, Leif S Ludwig, Donna S Neuberg, Haesook T Kim, Shuqiang Li, Lars Bullinger, Jerome Ritz, Gad A Getz, Jacqueline S Garcia, Robert J Soiffer, Kenneth J Livak, Catherine J Wu
Tracking rare single donor and recipient immune and leukemia cells after allogeneic hematopoietic cell transplantation using mitochondrial DNA mutations. Blood cancer discovery (2024)
Sophia Gross, Jana Ihlow, Leonie Busack, Kacper Adamiak, Jens Schrezenmeier, Julia Jesse, Michaela Schwarz, Anne Flörcken, Lam Giang Vuong, Kathrin Rieger, Jan Krönke, Philipp le Coutre, Vivien Boldt, Ann-Christin von Brünneck, David Horst, Thomas Burmeister, Igor-Wolfgang Blau, Ulrich Bernd Keller, Lars Bullinger, Jörg Westermann
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy. Blood cancer journal 14 (1) (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia 38 (9) (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia 38 (9) (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia (2024)
Alberto Hernandez-Sanchez, Teresa González, Marta Sobas, Eric Sträng, Gastone C Castellani, María Abáigar, Peter J M Valk, Ángela Villaverde Ramiro, Axel Benner, Klaus H Metzeler, Raúl Azibeiro, Jesse Marc Tettero, Joaquin Martinez Lopez, Marta Pratcorona, Javier Martínez Elicegui, Kenneth Ian Mills, Christian Thiede, Guillermo F Sanz, Konstanze Döhner, Michael Heuser, Torsten Haferlach, Amin T Turki, Dirk Reinhardt, Renate Schulze-Rath, Martje Barbus, Jesús María Hernández-Rivas, Brian James Patrick Huntly, Gert Ossenkoppele, Hartmut Döhner, Lars Bullinger
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. Leukemia 38 (9) (2024)
Eva Kaebisch, Marco Frentsch, Marie Luise Hütter-Krönke, Giang Lam Vuong, David Busch, Lucie Loyal, Larissa Henze, Stanislav Rosnev, Igor-Wolfgang Blau, Andreas Thiel, Dieter Beule, Lars Bullinger, Benedikt Obermayer, Il-Kang Na
Comparable CD8 + T-cell responses to SARS-CoV-2 vaccination in single-cell transcriptomics of recently allogeneic transplanted patients and healthy individuals. Journal of medical virology 96 (3) (2024)
Daniel Noerenberg, Franziska Briest, Cornelius Hennch, Kenichi Yoshida, Raphael Hablesreiter, Yasuhide Takeuchi, Hiroo Ueno, Annette M Staiger, Marita Ziepert, Fazila Asmar, Benjamin N Locher, Erika Tóth, Thomas Weber, Rose-Marie Amini, Wolfram Klapper, Maria Bouzani, Viola Poeschel, Andreas Rosenwald, Gerhard Held, Elias Campo, Naveed Ishaque, Kostas Stamatopoulos, George Kanellis, Ioannis Anagnostopoulos, Lars Bullinger, Neta Goldschmidt, Pier Luigi Luigi Zinzani, Csaba Bödör, Richard Rosenquist, Theodoros P Vassilakopoulos, German Ott, Seishi Ogawa, Frederik Damm
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Marion Subklewe, Ariel Perez, Gloria Iacoboni, Viktoria Blumenberg, Veit L Bücklein, Simon Völkl, Olaf Penack, Omar Albanyan, Sophia Stock, Fabian Müller, Philipp Karschnia, Agnese Petrera, Kayla M Reid, Rawan G Faramand, Marco L Davila, Karnav Modi, Erin A Dean, Christina A Bachmeier, Michael von Bergwelt-Baildon, Frederick L Locke, Wolfgang Andreas Bethge, Lars Bullinger, Andreas Mackensen, Pere Barba, Michael D Jain, Marion Subklewe
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion. Science advances 9 (38) (2023)
Tonio Johannes Lukas Lang, Frederik Damm, Lars Bullinger, Mareike Frick
Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia. Cancers 15 (18) (2023)
Jana K Striefler, Phung T Binder, Franziska Brandes, Daniel Rau, Silvan Wittenberg, David Kaul, Siyer Roohani, Armin Jarosch, Frederik M Schäfer, Robert Oellinger, Sven Märdian, Lars Bullinger, Kai-Uwe Eckardt, Jan Kruse, Anne Flörcken
Sarcoma Patients Admitted to the Intensive Care Unit (ICU): Predictive Relevance of Common Sepsis and Performance Parameters. Cancer management and research 15 (2023)
Yumi Tamura, Keita Yamane, Yohei Kawano, Lars Bullinger, Tristan Wirtz, Timm Weber, Sandrine Sander, Shun Ohki, Yasuo Kitajima, Satoshi Okada, Klaus Rajewsky, Tomoharu Yasuda
Concomitant Cytotoxic Effector Differentiation of CD4 + and CD8 + T Cells in Response to EBV-Infected B Cells. Cancers 14 (17) (2022)
Jan Braune, Kathrin Rieger, Olga Blau, Ulrich Bernd Keller, Lars Bullinger, Jan Krönke
Relapse of NPM1 -Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation. Case reports in hematology 2022 (2022)
Carlotta Welters, Maria Fernanda Lammoglia Cobo, Christian Alexander Stein, Meng-Tung Hsu, Amin Ben Hamza, Livius Penter, Xiaojing Chen, Christopher Buccitelli, Oliver Popp, Philipp Mertins, Kerstin Dietze, Lars Bullinger, Andreas Moosmann, Eric Blanc, Dieter Beule, Armin Gerbitz, Julian Strobel, Holger Hackstein, Hans-Peter Rahn, Klaus Dornmair, Thomas Blankenstein, Leo Hansmann
Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma. Cancer immunology research 10 (11) (2022)
Jan Braune, Kathrin Rieger, Olga Blau, Ulrich Bernd Keller, Lars Bullinger, Jan Krönke
Relapse of NPM1 -Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation. Case reports in hematology 2022 (2022)
Hannah J Uckelmann, Stephanie M Kim, Eric M Wong, Charles Hatton, Hugh Giovinazzo, Jayant Y Gadrey, Andrei V Krivtsov, Frank G Rücker, Konstanze Döhner, Gerard M McGeehan, Ross L Levine, Lars Bullinger, George S Vassiliou, Scott A Armstrong
Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia. Science (New York, N.Y.) 367 (6477) (2020)
Jonas Samuel Jutzi, Titiksha Basu, Maximilian Pellmann, Sandra Kaiser, Doris Steinemann, Mathijs Arnoud Sanders, Adil S A Hinai, Annelieke Zeilemaker, Sarolta Bojtine Kovacs, Christoph Koellerer, Jenny Ostendorp, Konrad Aumann, Wei Wang, Emmanuel Raffoux, Bruno Cassinat, Lars Bullinger, Brigitte Schlegelberger, Peter J M Valk, Heike Luise Pahl
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations. Blood 133 (16) (2019)